Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
Seok Hyeon Song, Seung Kook Baek, Min Woo Lee, Young Hoon Lee
Korean J Ophthalmol. 2020;34(1):46-55.   Published online 2020 Feb 4     DOI: https://doi.org/10.3341/kjo.2019.0044
Citations to this article as recorded by Crossref logo
Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, Liyu Zhang, Norbert Pfeiffer, Christina A. Korb, Adrian Gericke
Antioxidants.2024; 13(5): 594.     CrossRef
Optimizing treatment for diabetic macular edema during cataract surgery
Leo Ka Yu Chan, Sui Sum Lin, Fiona Chan, Danny Siu-Chun Ng
Frontiers in Endocrinology.2023;[Epub]     CrossRef
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery
Shan-Shan Li, Hui-Hui Wang, Yan-Ling Wang, Da-Wei Zhang, Xi Chen
International Ophthalmology.2022; 43(1): 271.     CrossRef
The Use of Bromfenac Ophthalmic Solution in Clinical Practice (Literature Review)
E. N. Matyukhina
Ophthalmology in Russia.2021; 18(4): 784.     CrossRef
Effects of Topical Prostaglandin Analog on Macular Thickness Following Cataract Surgery with Postoperative Topical Bromfenac Treatment
Kee Sup Park, Kyoung Nam Kim, Kyeung Min Kim, Han Min Lee, Sung Bok Lee, Nam Ho Lee, Chang-Sik Kim
Journal of Clinical Medicine.2020; 9(9): 2883.     CrossRef